Transarterial radioembolization (TARE) with yttrium 90 has increasingly been performed to
treat hepatocellular carcinoma (HCC). TARE was historically used as a palliative lobar …

As the incidence of hepatocellular carcinoma (HCC) and subsequent treatments with liver‐
directed therapies rise, the complexity of assessing lesion response has also increased. The …

Background: Liver Imaging Reporting and Data Systems (LI-RADS) Treatment Response
Algorithm (TRA) was created to provide a standardized assessment of hepatocellular …

Liver cirrhosis is the diffuse and advanced phase of liver disease. Several morphological
methods are used for imaging modalities. But, these modalities are biased and lack in …

Purpose Our purpose was to evaluate the accuracy of LI-RADS Treatment Response
Algorithm (LR-TRA) for assessing the viability of hepatocellular carcinoma (HCC) treated …

Purpose To summarize the magnetic resonance imaging manifestations of hepatocellular
carcinoma (HCC) with and without progression after stereotactic body radiation therapy …

HCC incidence continues to increase worldwide and is most frequently discovered at an
advanced stage when limited curative options are available. Combination locoregional …

The imaging findings after loco regional treatment of hepatocellular carcinoma are variable
based on the type of treatment used, the timing interval of imaging after treatment, and the …

Conventional transarterial chemoembolization (cTACE) utilizing ethiodized oil as a
chemotherapy carrier has become a standard treatment for intermediate-stage …

To comprehensive investigate the diagnostic efficacy of LR-5 and LR-4/5 by MRI LI-RADS of
suspected liver nodules. A comprehensive search of authenticated international databases …